BABIO Launches the HBcAb Hepatitis B Core Ab Rapid Test for Global Markets

SHANDONG, China – BABIO, a leading Chinese manufacturer specializing in innovative diagnostic tools, proudly announces the release of its HBcAb Hepatitis B Core Ab Rapid Test (Cassette) for global markets, particularly for users in Europe, the Americas, and Africa. This user-friendly test is designed for the qualitative detection of Hepatitis B virus core antibody (HBcAb) in human serum, plasma, and whole blood samples in vitro. Hepatitis B continues to be a major global health issue, with transmission through blood, sexual contact, and from mother to child being the primary modes. Early detection plays a crucial role in curbing the spread of the disease, making the HBcAb Hepatitis B Core Ab Rapid Test an essential tool for diagnostic applications.

The test is engineered to deliver fast and reliable results, providing healthcare providers with an auxiliary diagnosis of Hepatitis B infection. With a shelf life of up to 24 months when stored correctly, it is an ideal option for both clinics and laboratories. The rapid test kit is easy to use, providing clear visual results within just 20 minutes.

Key Features:

• Detects Hepatitis B Core Antibody (HBcAb) in human serum, plasma, or whole blood
• Simple, fast, and accurate results in just 20 minutes
• Ideal for use in clinics and laboratories
• Manufactured by BABIO, a trusted leader in diagnostic solutions

To learn more about the HBcAb Hepatitis B Core Ab Rapid Test and other cutting-edge products, visit BABIO’s official website at https://www.babiocorp.com. BABIO continues to lead the way in the global fight against Hepatitis B with high-quality, affordable diagnostic solutions.

For inquiries, product details, and ordering information, please contact us via our website.

#HepatitisB #HBcAbTest #MedicalDiagnostics #RapidTest #HepatitisBDetection #InVitroDiagnostics #HealthInnovation #GlobalHealth #BABIO